What Will Pfizer’s R&D Look Like a Year from Now?
By Jonathan D. Rockoff
Pfizer’s huge R&D shop is even bigger now that the company has swallowed Wyeth. To get a sense of the changes that could be in store, the Health Blog spoke today with the company’s two top R&D execs — Martin Mackay, a Pfizer veteran who will lead small-molecule work, and Mikael Dolsten, a former Wyeth executive who will oversee vaccines and biotech drugs.
Following a popular trend in the … Continue Reading
The Senate just killed that bill that would have blocked Medicare pay cuts to doctors. All of the Republicans opposed the bill, along with a handful of Dems. But that doesn’t mean the looming 21% pay cut is going to take effect next year.
There were some heated words on the Senate floor today as Congress debated what to do about planned Medicare pay cuts for doctors. We’ll get to the rhetoric in a minute, but first a bit of the back story.
It’s fine if parents want their sons to get Gardasil, Merck’s vaccine against HPV. But it shouldn’t be added to the list of routine vaccinations recommended for all boys, a CDC advisory panel said today.
Catch cancers early and treat them before they become deadly. That’s the idea behind cancer screening, and that’s clearly how it works with pap smears for cervical cancer and colonoscopy for colon cancer.